ZG-2492
ZG-2492 is an orally active LDHA inhibitor with an IC50 of 156 nM. ZG-2492 can reduce lactate production and induce cell cycle arrest and apoptosis in pancreatic cancer cells . ZG-2492 has antitumor activity and can be used in the research of tumors such as pancreatic cancer[1].
Product Specifications
CAS Number
3084810-37-4
UNSPSC
12352005
Target
Apoptosis; Lactate Dehydrogenase
Related Pathways
Apoptosis; Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Smiles
ClC1=CC=C(C#N)C=C1NS(C2=CC(N3CCN(CC3)CCC(O)=O)=CC=C2)(=O)=O
Molecular Formula
C20H21ClN4O4S
Molecular Weight
448.92
References & Citations
[1]Gong Q, et al. Machine-Learning-Driven Discovery of N-Phenylbenzenesulfonamides as a Novel Chemotype for Lactate Dehydrogenase A Inhibition with Anti-Pancreatic Cancer Activity. J Med Chem. 2025 Jul 24;68 (14) :14384-14404.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
LDHA
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
NBP3-20807C 0.1 mL
Mouse Monoclonal NCAM-1/CD56 Antibody (rNCAM1/8758) [DyLight 650]
Sign In for Pricing
View Details 
LV757906 1.0 µg DNA
B3GAT3P1 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)
Sign In for Pricing
View Details BNUB2770-100 1x 100 µL
TRAF1 (TNFR-Associated Factor 1) (Lymphomatoid Papulosis Marker) (TRAF1/2770), 0.2mg/mL
Sign In for Pricing
View Details